Form 4: Phreesia CEO Chaim Indig Awarded 130,000 RSUs

Phreesia, Inc. CEO and Director Chaim Indig was granted 130,000 Restricted Stock Units, vesting over four years, aligning executive incentives with long-term company performance.

Summary

• Chaim Indig, CEO and Director of Phreesia, Inc., was granted 130,000 Restricted Stock Units (RSUs).
• The RSUs were issued under the Phreesia, Inc. 2019 Stock Option and Incentive Plan.
• Each RSU represents the contingent right to receive one share of the Issuer's common stock.
• The grant was approved by the Compensation Committee of the Board of Directors on October 1, 2025.
• The RSUs vest over four years, with 10% vesting on December 5, 2026, 20% on December 5, 2027, 30% on December 5, 2028, and 40% on December 5, 2029, contingent on continued service.
• Following this transaction, Chaim Indig directly beneficially owns 1,382,608 shares and indirectly owns 255,000 shares through the Indig Dynasty Trust.

Sentiment

Score: 7

Explanation: The RSU grant is a positive signal of executive commitment and incentive alignment, a standard practice in corporate governance. While it implies future dilution, it's a normal part of compensation.

Positives

• The RSU grant aligns the CEO's long-term incentives with shareholder value creation, as vesting is contingent on continued service and future stock performance.
• The Compensation Committee approved the grant, indicating formal governance oversight of executive compensation.
• Increased direct beneficial ownership by the CEO demonstrates confidence in the company's future.

Negatives

• The issuance of RSUs, upon vesting, will result in a degree of share dilution, though this is a standard component of equity compensation plans.

Risks

• The vesting of RSUs is subject to the Reporting Person's continued service to the Issuer through each vesting date, meaning the full benefit is not guaranteed if service ceases.

Future Outlook

The RSU grant, with its multi-year vesting schedule extending to December 2029, indicates a long-term commitment from the CEO and an expectation of sustained company performance over this period.

Industry Context

Equity compensation, particularly through Restricted Stock Units (RSUs), is a standard practice across the technology and healthcare technology sectors to attract, retain, and incentivize key executives. This grant is consistent with typical executive compensation structures aimed at aligning management interests with long-term shareholder value.

Comparison to Industry Standards

• The use of RSUs as a primary component of executive long-term incentive compensation is a common practice among publicly traded technology and healthcare companies, similar to peers like Veeva Systems or Cerner (now Oracle Health).
• A multi-year vesting schedule (4 years in this case) is standard for executive equity grants, designed to promote long-term retention and performance, comparable to practices at companies such as Salesforce or Workday.
• The grant size of 130,000 RSUs for a CEO of a company like Phreesia would typically be evaluated against peer group compensation data to ensure competitiveness and alignment with company size and performance, though specific peer comparisons are not detailed in this filing.

Corporate Governance

Related Party Transactions

• The indirect beneficial ownership of 255,000 shares through the Indig Dynasty Trust, where the reporting person's immediate family are sole beneficiaries, constitutes a related party interest.

Stakeholder Impact

• Shareholders: Potential long-term benefit from CEO's incentivized performance; minor future dilution upon RSU vesting.
• Employees: May signal stability in leadership and a commitment to long-term growth.
• Management: Strong incentive for the CEO to remain with the company and drive long-term value.

Next Steps

• The RSUs will begin vesting on December 5, 2026, with subsequent vesting dates through December 5, 2029.
• The Reporting Person must continue service to the Issuer through each vesting date to receive the shares.

Key Dates

Recommendation

This Form 4 filing reports a routine executive compensation event (RSU grant) for the CEO. While it aligns management incentives with long-term shareholder value, it does not present new information that would fundamentally alter the investment thesis for Phreesia, Inc. Therefore, a 'hold' recommendation is appropriate, maintaining current positions while awaiting more substantive operational or financial updates.

Keywords

Phreesia, PHR, Chaim Indig, CEO, Director, Restricted Stock Units, RSU, Equity Compensation, Insider Trading, Form 4, Beneficial Ownership, Executive Compensation, Stock Option Plan